186 related articles for article (PubMed ID: 24141190)
1. Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
Padler-Karavani V
Cancer Lett; 2014 Sep; 352(1):102-12. PubMed ID: 24141190
[TBL] [Abstract][Full Text] [Related]
2. Glycans in immune recognition and response.
Amon R; Reuven EM; Leviatan Ben-Arye S; Padler-Karavani V
Carbohydr Res; 2014 May; 389():115-22. PubMed ID: 24680512
[TBL] [Abstract][Full Text] [Related]
3. Evolution of sialic acids: Implications in xenotransplant biology.
Paul A; Padler-Karavani V
Xenotransplantation; 2018 Nov; 25(6):e12424. PubMed ID: 29932472
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
Samraj AN; Bertrand KA; Luben R; Khedri Z; Yu H; Nguyen D; Gregg CJ; Diaz SL; Sawyer S; Chen X; Eliassen H; Padler-Karavani V; Wu K; Khaw KT; Willett W; Varki A
PLoS One; 2018; 13(6):e0197464. PubMed ID: 29912879
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS quantification of N-acetylneuraminic acid, N-glycolylneuraminic acid and ketodeoxynonulosonic acid levels in the urine and potential relationship with dietary sialic acid intake and disease in 3- to 5-year-old children.
Chen Y; Pan L; Liu N; Troy FA; Wang B
Br J Nutr; 2014 Jan; 111(2):332-41. PubMed ID: 23915700
[TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of N-acetyl and N-glycolylneuraminic acids in secreted and cell-associated glycoconjugates by two human osteosarcoma cell lines.
Tzanakakis GN; Nikitovic D; Katonis P; Kanakis I; Karamanos NK
Biomed Chromatogr; 2007 Apr; 21(4):406-9. PubMed ID: 17285685
[TBL] [Abstract][Full Text] [Related]
7. From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.
Dhar C; Sasmal A; Varki A
Front Immunol; 2019; 10():807. PubMed ID: 31057542
[TBL] [Abstract][Full Text] [Related]
8. Sialylation using N-glycolylneuraminyl phosphite donors to synthesize Neu5Gc-containing glycans.
Hanashima S; Tomiya T; Ishikawa D; Akai S; Sato K
Carbohydr Res; 2009 May; 344(8):959-65. PubMed ID: 19358980
[TBL] [Abstract][Full Text] [Related]
9. Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin.
Wang J; Shewell LK; Paton AW; Paton JC; Day CJ; Jennings MP
Biochem Biophys Res Commun; 2018 Jun; 500(3):765-771. PubMed ID: 29684349
[TBL] [Abstract][Full Text] [Related]
10. Colloquium paper: uniquely human evolution of sialic acid genetics and biology.
Varki A
Proc Natl Acad Sci U S A; 2010 May; 107 Suppl 2(Suppl 2):8939-46. PubMed ID: 20445087
[TBL] [Abstract][Full Text] [Related]
11. Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase.
Werner A; Horstkorte R; Glanz D; Biskup K; Blanchard V; Berger M; Bork K
Biol Chem; 2012 Aug; 393(8):777-83. PubMed ID: 22944680
[TBL] [Abstract][Full Text] [Related]
12. Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.
Boligan KF; Mesa C; Fernandez LE; von Gunten S
Cell Mol Life Sci; 2015 Apr; 72(7):1231-48. PubMed ID: 25487607
[TBL] [Abstract][Full Text] [Related]
13. Method establishment for discerned immunogenicity assessment of a recombinant glycoprotein containing nonhuman sialic acid Neu5Gc residues.
Montjovent MO; Zou L; Faust H; Abdolzade-Bavil A; Liu PM; Struwe P
Bioanalysis; 2017 Sep; 9(18):1385-1393. PubMed ID: 28956633
[TBL] [Abstract][Full Text] [Related]
14. Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution.
Varki A
Am J Phys Anthropol; 2001; Suppl 33(Suppl):54-69. PubMed ID: 11786991
[TBL] [Abstract][Full Text] [Related]
15. Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.
Yehuda S; Padler-Karavani V
Front Immunol; 2020; 11():21. PubMed ID: 32038661
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs.
Moons SJ; Adema GJ; Derks MT; Boltje TJ; Büll C
Glycobiology; 2019 Jun; 29(6):433-445. PubMed ID: 30913290
[TBL] [Abstract][Full Text] [Related]
17. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
Padler-Karavani V; Hurtado-Ziola N; Pu M; Yu H; Huang S; Muthana S; Chokhawala HA; Cao H; Secrest P; Friedmann-Morvinski D; Singer O; Ghaderi D; Verma IM; Liu YT; Messer K; Chen X; Varki A; Schwab R
Cancer Res; 2011 May; 71(9):3352-63. PubMed ID: 21505105
[TBL] [Abstract][Full Text] [Related]
18. Why Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?
Davies LR; Varki A
Top Curr Chem; 2015; 366():31-54. PubMed ID: 23471785
[TBL] [Abstract][Full Text] [Related]
19. Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies.
Leviatan Ben-Arye S; Schneider C; Yu H; Bashir S; Chen X; von Gunten S; Padler-Karavani V
Bioconjug Chem; 2019 May; 30(5):1565-1574. PubMed ID: 30994337
[TBL] [Abstract][Full Text] [Related]
20. Determination and distribution of N-acetyl- and N-glycolylneuraminic acids in culture media and cell-associated glycoconjugates from human malignant mesothelioma and adenocarcinoma cells.
Tzanakakis GN; Syrokou A; Kanakis I; Karamanos NK
Biomed Chromatogr; 2006 May; 20(5):434-9. PubMed ID: 16177958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
